deucravacitinib,Apremilast
bms,amgen
['psoriasis', 'deucrava', 'deucra', '$bmy']
$bmy u.s. food and drug administration approves sotyktu (deucravacitinib), oral treatment for adults with moderate-to-severe plaque psoriasis 45 seconds delayed.
Democratizing insights.

Not investment advice.